First-Line Treatment of HER2-Positive Metastatic Breast Cancer
2 Pogledi
• 07/03/23
0
0
Ugraditi
administrator
Pretplatnici
Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari